Carl Foster is the Chief Business Officer of Standigm, the leading workflow artificial intelligence (AI) drug discovery company. A veteran biotech and pharmaceutical executive, Foster expands strategic partnerships for AI drug discovery to help Standigm increase its growth and international impact.
He has more than 30 years of experience working for drug and platform technology companies in various areas, including genomics, proteomics and antibodies. Throughout his career – with Merck and Co., Cempra Pharmaceuticals, Jurilab, Nanogen, King Pharmaceuticals, Oxford GlycoSciences, Praecis Pharmaceuticals, Intracel BV, Ferghana Partners and now with Standigm – Foster has built a strong track record of business planning, establishing strategic relationships and financial modeling. Carl Foster holds an MBA in marketing and an M.S. in biochemistry from the University of Kansas.
